首页> 外文学位 >New insights into the molecular targets of lithium and valproate.
【24h】

New insights into the molecular targets of lithium and valproate.

机译:锂和丙戊酸分子靶标的新见解。

获取原文
获取原文并翻译 | 示例

摘要

Lithium (Li) and valproate (VPA) are two FDA approved drugs to treat bipolar disorder. Efforts to design more effective treatment for bipolar disorder are hampered by the fact that the therapeutic mechanisms of Li and VPA are not known. This study utilized the yeast model Saccharomyces cerevisiae to gain insight into the molecular targets of these drugs.; A classical genetic screen was used to identify yeast mutants hypersensitive to Li and VPA. This study showed that a loss of function allele of TPI1, which encodes triose phosphate isomerase, led to a 30-fold increase in intracellular DHAP levels. The increased DHAP in tpi1 strongly inhibited activity of the inositol biosynthetic enzyme myo-inositol-3-phosphate synthase and led to inositol auxotrophy. This study is the first to establish a connection between perturbation of glycolysis and inhibition of de novo inositol biosynthesis.; To further identify targets of Li and VPA, a genome-wide screen of 4815 yeast deletion strains was carried out to identify mutants with altered sensitivity to Li and VPA. This screen identified the secretory pathway as a possible target of both drugs, as 17 secretory mutants were hypersensitive to Li and VPA. In addition, 48 deletion mutants that are resistant to Li were identified. These included pho84, 9 mutants in the SAGA transcriptional regulatory complex that are required for PHO84 expression and 10 non-SAGA mutants that exhibited dramatically reduced expression of PHO84. Plasmid based expression of PHO84 or the human gene hOCT2, which shares homology with PHO84 complemented the Li resistance phenotype of the pho84 mutant. These results demonstrated that PHO84 is partly responsible for Li uptake in yeast.; Inositol depletion is an outcome of treatment with both Li and VPA, may thus be a component of the therapeutic mechanism. Therefore, we initiated studies to identify other inositol-depleting compounds similar in structure to VPA. This study found that 4 short straight-chain carboxylic acids (C6:0, C8:0, C9:0, C10:0) and 2 short branched-chain carboxylic acids, ethylhexanoate and methyloctanoate, caused inositol depletion. This study may shed light on potential new antibipolar drugs.
机译:锂(Li)和丙戊酸盐(VPA)是FDA批准的两种治疗躁郁症的药物。 Li和VPA的治疗机制尚不清楚的事实阻碍了设计用于双相情感障碍的更有效治疗的努力。该研究利用酵母模型酿酒酵母(Saccharomyces cerevisiae)深入了解了这些药物的分子靶标。使用经典的遗传筛选来鉴定对Li和VPA高度敏感的酵母突变体。这项研究表明,编码三糖磷酸异构酶的TPI1功能等位基因的缺失导致细胞内DHAP水平增加30倍。 tpi1中增加的DHAP强烈抑制了肌醇生物合成酶肌醇3磷酸合酶的活性,并导致肌醇营养缺陷。这项研究是第一个在糖酵解扰动和抑制从头肌醇生物合成之间建立联系的研究。为了进一步鉴定Li和VPA的靶标,进行了4815个酵母缺失菌株的全基因组筛选,以鉴定对Li和VPA敏感性改变的突变体。此筛查将分泌途径确定为两种药物的可能靶标,因为17种分泌突变体对Li和VPA过敏。另外,鉴定了48个抗Li的缺失突变体。其中包括pho84,SAGA转录调控复合物中的9个PHO84表达所需的突变体和10个非PGA84表达显着降低的非SAGA突变体。基于质粒的PHO84或与PHO84同源的人类基因hOCT2的表达补充了pho84突变体的Li抗性表型。这些结果表明PHO84部分负责酵母中的Li摄取。肌醇消耗是使用Li和VPA进行治疗的结果,因此可能是治疗机制的组成部分。因此,我们启动了研究,以鉴定其他结构类似于VPA的消耗肌醇的化合物。这项研究发现,4种短直链羧酸(C6:0,C8:0,C9:0,C10:0)和2种短支链羧酸(己酸乙酯和辛酸甲酯)会造成肌醇消耗。这项研究可能会揭示潜在的新型抗双极药物。

著录项

  • 作者

    Shi, Yihui.;

  • 作者单位

    Wayne State University.;

  • 授予单位 Wayne State University.;
  • 学科 Biology General.; Biology Microbiology.; Chemistry Biochemistry.; Biology Molecular.; Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2005
  • 页码 136 p.
  • 总页数 136
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 普通生物学;微生物学;生物化学;分子遗传学;药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号